Lack of pain Ischemic optic neuropathy, NMO-associated optic neuritis ... urgent evaluation for progressive multifocal leukoencephalopathy. Uveitis affects 1–2% of MS patients and usually ...

Discover the multiple sclerosis (MS) patterns that standard brain scans frequently overlook and why these missed indicators ...

A Ghanaian and survivor of multiple sclerosis, Nathalie Busari, tells GRACE EDEMA how she regained her sight and the ability ...

Multiple sclerosis is a progressive condition where the brain and the spinal cord get affected due to damage to the myelin ...

Racial and ethnic differences in the severity, prognosis, and mortality of multiple sclerosis (MS) have been the focus of ...

Most MS patients start with the relapsing-remitting form of the disease, where deterioration occurs between periods of stability. Over time, many then transition to secondary progressive MS ...

Optic neuritis occurs frequently in patients with multiple sclerosis and often is the first manifestation of the disease. It is characterized by a decrement in visual acuity, loss of color vision ...

YUFLYMA® (adalimumab-aaty) is a high-concentration (100mg/mL) and citrate-free formulation of Humira® (adalimumab) biosimilar ...

There is a much greater need for new therapies for progressive forms of MS than for relapsing forms of the disease. While relapsing forms are characterised by sudden attacks associated with ...

Mobility complications are often the first sign that relapsing-remitting multiple sclerosis (RRMS) is transitioning into secondary-progressive multiple sclerosis (SPMS). With this progression ...